Central European Time Zone (CET)

Dr. F. Javier de Santiago
MD Anderson Cancer Center Madrid, Spain
Dr. Pedro T. Ramirez
MD Anderson Cancer Center, Houston, USA
Dr. Raúl Márquez
MD Anderson Cancer Center Madrid, Spain
Moderator:
Dr. Stéphanie Lheureux
Princess Margaret Cancer Center, Toronto, Canada
15:40 - 16:00What should I offer my ovarian cancer patients as 1st line?
Dr. Raúl Márquez
MD Anderson Cancer Center Madrid, Spain
16:00 - 16:20Recurrent ovarian cancer: PARPi, bevacizumab or second-line therapy?
Dr. Robert L. Coleman
US Oncology Network, USA
16:20 - 16:40PARPi in front line: current challenges and future directions
Dr. Ainhoa Madariaga
Princess Margaret Cancer Centre, Toronto, Canada
16:40 - 17:00Questions & Discussion
Moderator:
Dr. Christina Fotopoulou
Queen Charlotte's & Chelsea Hospital, London, UK
17:15 - 17:35Surgery in recurrent ovarian cancer? PRO
Dr. Andreas Du Bois
Kliniken Essen Mitte, Essen, Germany
17:35 - 17:55Surgery in recurrent ovarian cancer? CON
Dr. Robert L. Coleman.
US Oncology Network, USA
17:55 - 18:15Round table
18:15 - 18:35Immunotherapy in ovarian cancer: walking in circles?
Dr. Amir A. Jazaeri
MD Anderson Cancer Center, Houston, USA
18:35 - 18:45Questions & Discussion